PRACTECAL-PKPD Sub Study
Conditions:   Multi-drug Resistant Tuberculosis;   Extensively Drug-Resistant Tuberculosis;   Pulmonary Tuberculosis Interventions:   Drug: Bedaquiline;   Drug: Pretomanid;   Drug: Moxifloxacin;   Drug: Linezolid;   Drug: Clofazimine Sponsors:   Medecins Sans Frontieres, Netherlands;   London School of Hygiene and Tropical Medicine;   Global Alliance for TB Drug Development;   University College, London;   Drugs for Neglected Diseases;   Swiss Tropical & Public Health Institute;   eResearch Technology, Inc.;   Ministry of Health, Republic of Uzbekistan;   World Hea...
Source: ClinicalTrials.gov - September 9, 2019 Category: Research Source Type: clinical trials

PRACTECAL-PKPD: Sub-study for TB-PRACTECAL Clinical Trial
Conditions:   Multi-drug Resistant Tuberculosis;   Extensively Drug-Resistant Tuberculosis;   Pulmonary Tuberculosis Interventions:   Drug: Bedaquiline;   Drug: Pretomanid;   Drug: Moxifloxacin;   Drug: Linezolid;   Drug: Clofazimine Sponsors:   Medecins Sans Frontieres, Netherlands;   London School of Hygiene and Tropical Medicine;   Global Alliance for TB Drug Development;   University College, London;   Drugs for Neglected Diseases;   Swiss Tropical & Public Health Institute;   eResearch Technology, Inc.;   Ministry of Health, Republic of Uzbekistan;   World Hea...
Source: ClinicalTrials.gov - September 9, 2019 Category: Research Source Type: clinical trials

PRACTECAL-PKPD Sub Study
Conditions:   Multi-drug Resistant Tuberculosis;   Extensively Drug-Resistant Tuberculosis;   Pulmonary Tuberculosis Interventions:   Drug: Bedaquiline;   Drug: Pretomanid;   Drug: Moxifloxacin;   Drug: Linezolid;   Drug: Clofazimine Sponsors:   Medecins Sans Frontieres, Netherlands;   London School of Hygiene and Tropical Medicine;   Global Alliance for TB Drug Development;   University College, London;   Drugs for Neglected Diseases;   Swiss Tropical & Public Health Institute;   eResearch Technology, Inc.;   Ministry of Health, Republic of Uzbekistan;   World Hea...
Source: ClinicalTrials.gov - September 9, 2019 Category: Research Source Type: clinical trials